Order Article Reprints

Di Micco P, Tufano A, Cardillo G, Imbalzano E, Amitrano M, Lodigiani C, Bellizzi A, Camporese G, Cavalli A, De Stefano C, et al. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study. Viruses. 2021; 13(9):1720. https://doi.org/10.3390/v13091720

Di Micco, Pierpaolo, Antonella Tufano, Giuseppe Cardillo, Egidio Imbalzano, Maria Amitrano, Corrado Lodigiani, Annamaria Bellizzi, Giuseppe Camporese, Antonella Cavalli, Carmela De Stefano, and et al. 2021. "The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study" Viruses 13, no. 9: 1720. https://doi.org/10.3390/v13091720

Di Micco, P., Tufano, A., Cardillo, G., Imbalzano, E., Amitrano, M., Lodigiani, C., Bellizzi, A., Camporese, G., Cavalli, A., De Stefano, C., Russo, V., Voza, A., Perrella, A., & Prandoni, P. (2021). The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study. Viruses, 13(9), 1720. https://doi.org/10.3390/v13091720